Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan De Rijck

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Trends in Pharmacological Sciences|June 14, 2016
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage LeukemiaKaterina Cermakova, Caroline Weydert, Frauke Christ, et al.
The Journal of Biological Chemistry|March 18, 2014
Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatinJelle Hendrix, Bart van Heertum, Els Vanstreels, et al.
Molecular Therapy. Nucleic Acids|March 7, 2013
Transient Expression of an LEDGF/p75 Chimera Retargets Lentivector Integration and Functionally Rescues in a Model for X-CGDSofie Vets, Jan De Rijck, Christian Brendel, et al.
AIDS (London, England)|December 6, 2012
Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressorsRik Schrijvers, Jonas Demeulemeester, Jan De Rijck, et al.
Retrovirology|October 11, 2012
HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cellsRik Schrijvers, Sofie Vets, Jan De Rijck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2010
LEDGF hybrids efficiently retarget lentiviral integration into heterochromatinRik Gijsbers, Keshet Ronen, Sofie Vets, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory ElementsSara El Ashkar, Jan De Rijck, Jonas Demeulemeester, et al.
The Journal of Biological Chemistry|October 12, 2011
Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targetingRik Gijsbers, Sofie Vets, Jan De Rijck, et al.
Journal of Virology|September 22, 2006
Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replicationJan De Rijck, Linos Vandekerckhove, Rik Gijsbers, et al.
Journal of Molecular Biology|August 3, 2007
Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75Koen Bartholomeeusen, Jan De Rijck, Katrien Busschots, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Trends in Pharmacological Sciences|June 14, 2016
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage LeukemiaKaterina Cermakova, Caroline Weydert, Frauke Christ, et al.
The Journal of Biological Chemistry|March 18, 2014
Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatinJelle Hendrix, Bart van Heertum, Els Vanstreels, et al.
Molecular Therapy. Nucleic Acids|March 7, 2013
Transient Expression of an LEDGF/p75 Chimera Retargets Lentivector Integration and Functionally Rescues in a Model for X-CGDSofie Vets, Jan De Rijck, Christian Brendel, et al.
AIDS (London, England)|December 6, 2012
Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressorsRik Schrijvers, Jonas Demeulemeester, Jan De Rijck, et al.
Retrovirology|October 11, 2012
HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cellsRik Schrijvers, Sofie Vets, Jan De Rijck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2010
LEDGF hybrids efficiently retarget lentiviral integration into heterochromatinRik Gijsbers, Keshet Ronen, Sofie Vets, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory ElementsSara El Ashkar, Jan De Rijck, Jonas Demeulemeester, et al.
The Journal of Biological Chemistry|October 12, 2011
Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targetingRik Gijsbers, Sofie Vets, Jan De Rijck, et al.
Journal of Virology|September 22, 2006
Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replicationJan De Rijck, Linos Vandekerckhove, Rik Gijsbers, et al.
Journal of Molecular Biology|August 3, 2007
Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75Koen Bartholomeeusen, Jan De Rijck, Katrien Busschots, et al.
Pageof 5